Clinical Research Directory
Browse clinical research sites, groups, and studies.
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Sponsor: Vanda Pharmaceuticals
Summary
An open label study to investigate the safety and efficacy of ponesimod in participants with moderate-to-severe chronic plaque psoriasis
Official title: A Multicenter, Open Label Study to Investigate the Safety and Efficacy of Ponesimod in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2026-02-17
Completion Date
2028-12
Last Updated
2026-06-11
Healthy Volunteers
No
Interventions
Ponesimod
Oral Tablet
Locations (4)
Vanda Investigational Site
Glendale, Arizona, United States
Vanda Investigational Site
Fremont, California, United States
Vanda Investigational Site
Rochester, New York, United States
Vanda Investigational Site
Spokane, Washington, United States